AndrewZureickMD

Clinical Assistant Professor, Department of Radiation Oncology

Dr. Zureick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Andrew Zureick is a Clinical Assistant Professor of Radiation Oncology at UPMC Presbyterian-Shadyside in Pittsburgh, PA. He received an A.B. in Chemistry with High Honors and graduated Summa Cum Laude from Dartmouth College in 2013. He received his M.D. from the University of Michigan Medical School in 2018. He completed a Transitional Year Internship in 2019 and his residency training in Radiation Oncology in 2013 at William Beaumont Hospital in Royal Oak, MI (now Corewell Health East). His clinical practice and expertise is in CNS Radiation Oncology, including primary brain and spine tumors, brain and spine metastases, stereotactic radiosurgery, and palliative care. He has published multiple manuscripts and remains active in clinical research.

Corewell Health William Beaumont University HospitalResidency, Radiation Oncology, 2019 - 2023
University of Michigan Medical SchoolClass of 2018
Dartmouth CollegeA.B., Chemistry, High Honors, Summa cum Laude, 2009 - 2013

Lucien J. Rubinstein Award American Brain Tumor Association, 2015
Scientific Merit Award for Best Abstract PTCOG - North America, 2014
Marvin Gordon, M.D. and Sylvia Gordon Scholarship University of Michigan Medical School, 2013
Barry M. Goldwater Scholar Goldwater Scholarship and Excellence in Education Program, 2012
Join now to see all

PubMed

6 citations
Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review.
Blair Murphy, Andrew Jackson, Johnnie K Bass, Derek S Tsang, Cecile M Ronckers
International Journal of Radiation Oncology, Biology, Physics. 2024-06-01
Breast Conserving Therapy for Patients With Prior Cosmetic Implant-Based Breast Augmentation: Outcomes and Comparison Against a Matched Cohort.
Vincent P Grzywacz, Anna V Lehrberg, Thomas J Quinn, Andrew H Zureick, Neha Sarvepalli
Clinical Breast Cancer. 2024-04-01
2 citations
Breast Irradiation Is Well Tolerated in Carriers of a Pathogenic ATM Variant.
Andrew H Zureick, Dana Zakalik, Thomas J Quinn, Tara S Rangarajan, Vincent P Grzywacz
Practical Radiation Oncology. 2023-09-22

Journal Articles

Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review.
Murphy B, Jackson A, Bass JK, Tsang DS, Ronckers CM, Kremer L, Baliga S, Olch A, Zureick AH, Jee KW, Constine LS, Yock TI., Int J Rad Onc Biol Phys, 10/19/2023
Greener, Brighter
Bian RR, Zureick AH, Porter RS, Stojan JN, Academic Medicine, 2016
Synthesis and Structure of Platinum Bis(phospholane) Complexes Pt(diphos*)(R)(X), Catalyst Precursors for Asymmetric Phosphine Alkylation
Guino-o MA, Zureick AH, Blank NF, Anderson BJ, Chapp TW, Kim Y, Glueck DS, Organometallics, 9/2012

Books/Book Chapters

What Every Science Student Should Know
Bauer JL, Kim YJ, Zureick AH, Lee DKUniversity of Chicago Press, Chicago, IL2016

Abstracts/Posters

Why Won’t You Answer Me? A Rare Case of Mutism
Zureick AH, Stojan JN, J Hosp Med, San Diego, CA (Society of Hospital Medicine), 3/7/2016
‘How We Learn May Not Always Be Good For Us’ – Analytics of Students’ Study Strategies, Educational Resource Choices, and Learning Success in a Medical Histology Course
Hortsch M, Holaday LW, Selvig D, Burk-Rafel J, Zureick AH, Purkiss J, FASEB J, Boston, MA (Experimental Biology), 3/30/2015
Proton RT for Pediatric CNS Tumor Survivors: Correlating Dose to Neuroanatomy with Cognitive Outcomes
Zureick AH, Nichols AJ, Pulsifer MB, Niemerko A, Paganetti H, Grassberger C, Fullerton BC, Khan F, MacDonald SM, Tarbell NJ, Yock TI, Int J. Part Ther, Houston, TX (PTCOG-NA), 12/31/2014
New chiral platinum bis (phospholane) complexes: Synthesis, characterization, and structure-reactivity-selectivity relationships in catalysis
Zureick AH, Blank NF, Guino-o MA, Anderson BJ, Chapp TW, Kim Y, Glueck DS, Rheingold AL, American Chemical Society 244th Annual Meeting, Philadelphia, PA, 8/21/2012
Two distinct Th9 subpopulations are generated by activating naïve CD4 cells with either antigen/APC, or anti-CD3/CD28 antibodies
Tan C, Vistica BP, Nugent L, Zureick AH, Shi G, Gery I, J Immunol, 2011
Join now to see all

ABTA's 2014 Lucien Rubinstein Award recipienthttp://www.abta.org/about-us/news/press-releases/american-brain-tumor-7.html
How four med students landed a major publishing dealhttp://www.ama-assn.org/ama/ama-wire/post/four-med-students-landed-major-publishing-deal